Shelter Pharma Ltd - 543963 - Announcement under Regulation 30 (LODR)-Award of Order Receipt of Order
Shelter Pharma Limited secured order from Berlin International Medical Co for $ 1,20,000.06-06-2024
Shelter Pharma Ltd - 543963 - Announcement under Regulation 30 (LODR)-Award of Order Receipt of Order
Shelter Pharma Limited secured order from Berlin International Medical Co for $ 1,20,000.Shelter Pharma Ltd - 543963 - Announcement under Regulation 30 (LODR)-Award of Order Receipt of Order
Shelter Pharma secured order from Genet International for Rupees 8.68 Lakhs ($ 10450) approximately.Shelter Pharma Ltd - 543963 - Non-Applicability Of Regulation 23(9) As Per Regulation 15 Of Chapter IV Of SEBI (LODR) Regulations, 2015 For The Half Year And Year Ended March 2024.
Non Applicability of Regulation of 23(9) and 15 of LODR 2015Shelter Pharma Ltd - 543963 - Intimation Under Regulation 30 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015 Regarding Re-Appointment Of CA Mohammadaltaf Rasulbhai Sachora (ALTAF SACHORA & CO), FRN NO: 138017W Chartered Accountants As Internal Auditor
Reappointment of Internal Auditor M/S Altaf Sachora & Co for the financial year 2024-2025Shelter Pharma Ltd - 543963 - Intimation Under Regulation 30 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015 Regarding Reappointment Of M/S. Murtuza Mandorwala & Associates As Secretarial Auditor
Reappointment of Secretarial Auditor M/S Murtuza Mandorwala & Associates for the financial year 2024-2025Shelter Pharma Ltd - 543963 - Board Meeting Outcome for Board Meeting Outcome For Outcome Of Board Meeting Held Today On 24.05.2024
1. Approval of Standalone audited Financial Result for the Half year and Year ended on 31st March, 2024 as per Regulation 33 of the SEBI (LODR) Regulations, 2015 2. Re-Reappointment of CA Mohammadaltaf Rasulbhai Sachora (ALTAF SACHORA & CO), FRN NO: 138017W, Ahmedabad , as Internal Auditors of the Company to conduct the Internal Audit for the financial year 2024-25 3. Re-Reappointment of M/s. Murtuza Mandorwala & Associates, Practicing Company Secretary, as Secretarial Auditor of the Company for the Year 2024-25Shelter Pharma Ltd - 543963 - Approval Of Audited Financial Results For Half Year And Financial Year Ended On 31.03.2024 Along With Auditor''''s Report With Unmodified Opinion (Free From Any Qualifications) On The Audited Financial Results
Approval of Audited Financial Result for Half year and Financial year ended on 31st March, 2024Shelter Pharma Ltd - 543963 - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 24Th May, 2024
Shelter Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/05/2024 ,inter alia, to consider and approve To consider, approve and take on record the Audited Financial Results for the half year ended and year ended on March 31, 2024 as per Regulation 33 of the SEBI (LODR) Regulation, 2015Shelter Pharma Ltd - 543963 - Intimation Under Regulation 30 And Other Applicable Regulations Of SEBI (Listing Obligation & Disclosure Requirements) Regulations, 2015
Establishment of Corporate Office of the Company.Shelter Pharma Ltd - 543963 - Compliance Certificate Under Regulation 7(3) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Compliance Certificate under Regulation 7(3) SEBI LODR 2015